Cerebral thrombosis is a blood clot that forms in a blood vessel inside the brain, blocking normal blood flow and potentially causing a stroke. It can occur in the arteries that supply oxygen to brain tissue or in the veins and sinuses that drain blood away from the brain. The arterial form is one of the most common causes of ischemic stroke, while the venous form, known as cerebral venous thrombosis, is rarer but increasingly recognized. Both types can cause serious brain damage if not treated quickly.
How a Blood Clot Damages the Brain
When a clot blocks a brain artery, the tissue downstream is starved of oxygen and begins to die within minutes. This is the classic ischemic stroke, and the damage depends on which artery is blocked and how long blood flow is cut off.
Venous thrombosis works differently. When a clot blocks the veins or large drainage channels (sinuses) in the brain, blood backs up. The rising pressure in small veins and capillaries triggers a chain reaction: reduced blood flow causes oxygen-starved tissue to swell, the barrier between blood vessels and brain tissue breaks down, and in severe cases, fragile vessels rupture and bleed into surrounding brain tissue. About 30% to 40% of people with venous thrombosis already have bleeding visible on brain scans at the time of diagnosis, even before any treatment begins.
The blocked sinuses also interfere with how the brain reabsorbs cerebrospinal fluid, the liquid that cushions the brain and spinal cord. Normally this fluid drains into the large sinuses. When those sinuses are clotted, fluid accumulates and pressure inside the skull climbs further, creating a dangerous feedback loop that worsens swelling and bleeding.
Symptoms to Recognize
Arterial cerebral thrombosis typically causes the sudden, recognizable signs of stroke: one-sided weakness or numbness, slurred speech, confusion, vision loss, or trouble walking. Symptoms usually appear within seconds to minutes.
Venous thrombosis is trickier to spot because symptoms often develop gradually over days or even weeks. The most common symptom is a severe, persistent headache that doesn’t respond well to typical painkillers and may worsen when lying down. As pressure inside the skull rises, other symptoms can follow: seizures, blurred or double vision, weakness on one side of the body, difficulty speaking, and changes in alertness or consciousness. Because these symptoms overlap with migraines, meningitis, and other conditions, venous thrombosis is frequently missed or diagnosed late.
Who Is at Risk
The risk factors differ somewhat depending on whether the clot forms in an artery or a vein. Arterial clots are closely tied to the same cardiovascular risks behind heart attacks: high blood pressure, high cholesterol, diabetes, smoking, and atherosclerosis (the buildup of fatty plaque in artery walls). Age is a major factor, with risk climbing sharply after 55.
Venous thrombosis has a distinctly different risk profile. About 70% of cases occur in women, largely because of hormonal factors. Key risk factors for adults include:
- Hormonal contraceptives: oral birth control pills significantly raise clot risk, and people who have had venous thrombosis are typically advised to avoid them
- Pregnancy and the postpartum period: particularly the first few weeks after delivery
- Inherited clotting disorders: conditions like Factor V Leiden mutation, protein C or S deficiency, and antithrombin deficiency
- Autoimmune and inflammatory diseases: lupus, Behçet syndrome, inflammatory bowel diseases like Crohn’s and ulcerative colitis
- Cancer: which increases blood clot risk throughout the body
- Obesity
In children and infants, the triggers tend to be different. Dehydration, infections, sickle cell anemia, iron deficiency, and congenital heart disease all raise risk. In newborns, the presentation is particularly vague. Infants may show seizures, unusual floppiness, weak reflexes, or general signs of brain distress. Roughly 27% of affected preterm infants show no obvious symptoms at all, with the clot discovered incidentally during brain imaging done for other reasons. Maternal factors like preeclampsia, high blood pressure, and complicated deliveries (such as those requiring forceps or vacuum assistance) also contribute.
How It Is Treated
For arterial cerebral thrombosis, treatment follows standard stroke protocols. The priority is restoring blood flow as fast as possible, either with clot-dissolving medication given intravenously or, in some cases, a procedure to physically remove the clot. Time is critical: the sooner treatment starts, the less brain tissue is permanently lost.
Venous thrombosis is treated with blood thinners (anticoagulants). Current guidelines recommend starting with injectable anticoagulants, then transitioning to an oral blood thinner. This might seem counterintuitive when bleeding is already present inside the skull, but anticoagulation prevents the clot from growing and allows the body to gradually dissolve it. Even patients who already have some brain bleeding at diagnosis are treated this way, because the underlying clot is what drives ongoing damage.
How long you stay on blood thinners depends on why the clot formed. If a clear, temporary trigger caused it, like oral contraceptives or a recent surgery, treatment typically lasts 3 to 12 months. If the cause is a chronic clotting disorder or if you’ve had previous blood clots elsewhere in the body, treatment may continue indefinitely. For women who develop venous thrombosis during pregnancy, full-dose injectable anticoagulants continue through the rest of the pregnancy and for at least 6 weeks after delivery, with a minimum total treatment duration of 3 months.
Recovery and Long-Term Outlook
The prognosis for cerebral thrombosis depends heavily on the type, location, and how quickly treatment begins. For arterial strokes caused by thrombosis, outcomes range widely. Small clots caught early may leave minimal lasting effects, while large strokes can cause permanent disability.
Venous thrombosis generally carries a better prognosis than many people expect. In a large study of over 1,500 patients (median age 40), early mortality within 30 days was 3.4%, and one-year mortality was 5.6%. Most deaths occur in the acute phase or within the first year. The majority of survivors recover well, though some experience lasting headaches, seizures, or cognitive difficulties that require ongoing management.
For infants and preterm babies, the picture is more complex. Brain imaging frequently shows white matter injury, with deep and surrounding-the-ventricles white matter lesions appearing in roughly 42% to 46% of cases. These injuries can affect long-term neurological development, making early detection and follow-up imaging important.
After recovering from venous thrombosis, the risk of a recurrent clot, either in the brain or elsewhere, remains a concern. Your medical team will weigh that risk against the bleeding risks of continued anticoagulation when deciding how long to continue treatment. Lifestyle adjustments, like avoiding hormonal contraceptives and staying well-hydrated, also play a role in reducing future risk.